FDA Approves First Neurostimulation Device for PTSD

Neurovalens' Modius Spero has become the first FDA-approved neuromodulation device for treating PTSD symptoms, with veterans gaining access through the VA beginning summer 2026. This approval marks a significant milestone in neurostimulation device development for mental health conditions.